Metraipolis › archive › dc_06441d536fda

Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial — Europe PMC PMID:41871187

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41871187
DOI
10.1155/jdr/2960736
License (as archived)
solo-consultazione
Archived
2026-11-07T03:34:13.629Z
SHA-256 of the archived text
6b8fe6147aae274435d144a6e2a8699729feb3cf4c3a2e2b47f7c18707805cec
Stable URL of this page
https://metraipolis.com/documento/dc_06441d536fda

How to cite

Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial — Europe PMC PMID:41871187 — Europe PMC (en), https://europepmc.org/article/MED/41871187 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_06441d536fda (Metraipolis archive dc_06441d536fda, sha256 6b8fe6147aae274435d144a6e2a8699729feb3cf4c3a2e2b47f7c18707805cec)
BibTeX
@misc{dc06441d536fda,
  title = {Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial — Europe PMC PMID:41871187},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41871187},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_06441d536fda; sha256 6b8fe6147aae274435d144a6e2a8699729feb3cf4c3a2e2b47f7c18707805cec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41871187. Agents can read the archived copy with the MCP tool read_document.